Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

New pieces to the prostate cancer puzzle

Nature Medicine volume 5, pages 264–265 (1999)Cite this article

Abstract

Expression of different pp32 gene family members and cross-talk between the HER-2/neu and androgen receptor signaling pathways may be involved in prostate cancer development (pages 275–285).

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Kadkol, S.S., Brody, J.R., Pevsner, J., Bai, J. & Pasternack, G.R. Modulation of oncogenic potential by alternative gene usage in human prostate cancer. Nature Med. 5, 275–279 (1999).

    Article  CAS  Google Scholar 

  2. Craft, N., Shostak, Y., Carey M. & Sawyers, S.L. A mechanism for hormone independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase. Nature Med. 5, 280–285 (1999).

    Article  CAS  Google Scholar 

  3. Kadkol, S.S., Brody, J.R., Epstein, J.I., Kuhajda, F.P. & Pasternack, G.R. Novel nuclear phosphoprotein pp32 is highly expressed in intermediate-and high-grade prostate cancer. Prostate 34, 231–237 ( 1998).

    Article  CAS  Google Scholar 

  4. Malek, S.N., Katumuluwa, A.I. & Pasternack, G.R. Identification and preliminary characterization of two related proliferation-associated nuclear phosphoproteins. J. Biol. Chem. 265, 13400–13409 (1990).

    CAS  PubMed  Google Scholar 

  5. Huggins, C. & Hodges C.V. The effect of castration, of estrogens and of androgen injection on serum phosphatase in metastatic carcinoma of prostate. Cancer Res. 1, 293–297 ( 1941).

    CAS  Google Scholar 

  6. Visakorpi, T. et al. In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nature Genet. 9, 401–406 (1995).

    Article  CAS  Google Scholar 

  7. Kallioniemi, O.-P. & Visakorpi, T. Genetic basis and clonal evolution of human prostate cancer. Adv. Cancer Res. 68, 225–255 ( 1996).

    Article  CAS  Google Scholar 

  8. Miyamoto, H., Yeh, S., Wilding, G. & Chang, C. Promotion of agonist activity of anti-androgens by the androgen receptor co-activator, ARA70, in human prostate cancer DU145 cells. Proc. Natl. Acad. Sci. USA 95, 7379–7384 (1998).

    Article  CAS  Google Scholar 

  9. Klein, K.A. et al. Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice. Nature Med. 3, 402–408 (1997).

    Article  CAS  Google Scholar 

  10. Pharmacogenomics at work. (Editorial) Nature Biotech. 16, 885 (1998 ).

Download references

Author information

Authors and Affiliations

  1. Institute of Medical Technology, University of Tampere and Tampere University Hospital, Tampere, FIN-33101, Finland

    Tapio Visakorpi

Authors
  1. Tapio Visakorpi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Visakorpi, T. New pieces to the prostate cancer puzzle. Nat Med 5, 264–265 (1999). https://doi.org/10.1038/6472

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/6472

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing